相关实验视频

Updated: Jan 17, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

[¹⁸F]FDG PET/CT用于与波拉图祖马布维多丁含有疗法治疗的扩散性大B细胞淋巴瘤的结果预测

Congcong Yu^1,2,3,4, Jing Wang^1,2,3,4, Lin Chen^1,3,4

¹Department of Nuclear Medicine and Medical PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

European journal of nuclear medicine and molecular imaging

|September 19, 2025

概括

FDG PET/CT有效预测了接受Polatuzumab vedotin的扩散性大B细胞淋巴瘤 (DLBCL) 患者的结果. 代谢性瘤体积和随访扫描中的SUV平均值是无进展生存的关键指标.

科学领域:

在瘤学瘤学.
核医学就是核医学.
放射学放射学是一门学科.

背景情况:

扩散性大B细胞淋巴瘤 (DLBCL) 是一种侵略性的非霍奇金淋巴瘤.
包括Polatuzumab vedotin (Pola) 在内的新型治疗方案正在改善患者的治疗结果.
准确的预后工具对于指导DLBCL治疗策略至关重要.

研究的目的:

为了评估2-deoxy-2-[¹⁸F]-D-葡萄糖正子发射断层扫描/计算机断层扫描 ([¹⁸F]FDG PET/CT) 的预后意义在DLBCL患者中,这些患者接受了包含Pola的治疗方案.
从[¹⁸F]FDG PET/CT中识别关键代谢参数,从而预测治疗反应和存活率.

主要方法:

对39名DLBCL患者的回顾性分析,这些患者接受了包含Pola的治疗方案和治疗前[¹⁸F]FDG PET/CT.
使用基于后续PET扫描的卢加诺标准评估治疗反应.
使用SUV 4.0和41%SUVmax细分方法对FDG PET参数 (SUVmax,SUVmean,MTV,TLG) 的定量分析.
使用依赖时间的ROC曲线,考克斯回归和卡普兰-梅尔分析进行预测价值评估.

主要成果:

随访PET的完整代谢反应 (CMR) 与部分代谢反应 (PMR) 相比,与明显更好的结果有关.
来自SUV 4.0细分的代谢瘤体积 (MTV) 和总损伤糖解 (TLG) 显示出优异的预测性能.
多变量分析从第一次随访PET扫描中确定了SUVmean和MTV作为无进展生存 (PFS) 的独立预测因素.

结论:

[¹⁸F]FDG PET/CT在进行基于Pola的治疗的DLBCL患者预测治疗结果方面发挥着至关重要的作用.
早期评估代谢性瘤体积和后续PET扫描中的SUV平均值可以指导预后评估和治疗决策.
这些发现支持将[¹⁸F]FDG PET/CT纳入使用新疗法治疗DLBCL患者的常规监测.

关键词:

扩散性大B细胞淋巴瘤波拉图祖马布 (Polatuzumab) 是一种可见的药物.预测预后预测预测 [18F]FDG PET/CT 皮革/CT 皮革/CT 皮革/CT 皮革/CT

更多相关视频

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Automated Preparation of [⁶⁸Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...